Back to HALO
CONGRESS ASSET MANAGEMENT CO → HALO
CONGRESS ASSET MANAGEMENT CO HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$251.9M
Q3 2026
Peak value
$251.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $105.4M |
| Q4 2025 | $87.6M |
| Q1 2026 | $82.8M |
| Q2 2026 | $96.2M |
| Q3 2026 | $251.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $251.9M | 2.28M | — | — |
| Q2 2026 | $96.2M | 1.23M | — | — |
| Q1 2026 | $82.8M | 1.28M | — | — |
| Q4 2025 | $87.6M | 1.30M | — | — |
| Q3 2025 | $105.4M | 1.44M | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$236.6M
$176.7M
$148.6M